MADELEINE PHARMACEUTICALS, INC.
Biotech · Private
rMP3167, a recombinant human cardiac hormone (proANP 31-67) therapeutic for heart failure treatment
- Grants
- $3.9M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of a novel drug treatment for decompensated heart failure. | $1,996,767 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure | $887,140 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure | $1,044,010 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure | $1 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3090 | SYNLIBRIS, INC. | — | — |
| 3091 | ZETTA AI, LLC | — | — |
| 3092 | Technology Holding, LLC | — | — |
| 3093 | MADELEINE PHARMACEUTICALS, INC. | — | — |
| 3094 | AGYPHARMA, LLC | — | — |
| 3095 | TINY CARGO COMPANY, THE | — | — |
| 3096 | NEUROLUX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.